🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s MDT Holdings & Trades

First Buy
Q3 2015
Duration Held
38 Quarters
Largest Add
Q3 2017
+5.96 M Shares
Current Position
3.17 M Shares
$247.81 M Value

Renaissance Technologies (RenTech)'s MDT Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 3.17 M shares of Medtronic plc (MDT) worth $247.81 M, representing 0.34% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 38 quarters.

Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in MDT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2017, adding 5.96 M shares. Largest reduction occurred in Q4 2017, reducing 4.97 M shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Medtronic plc (MDT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Medtronic plc (MDT) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +3.17 M New Buy 3.17 M $78.23
Q3 2025 -432,541 Sold Out 0 $0.00
Q2 2025 +432,541 New Buy 432,541 $87.17
Q1 2025 -575,341 Sold Out 0 $0.00
Q4 2024 -737,300 Reduce 56.17% 575,341 $79.88
Q3 2024 +676,300 Add 106.28% 1.31 M $90.03
Q2 2024 +154,700 Add 32.12% 636,341 $78.71
Q1 2024 +12,800 Add 2.73% 481,641 $87.15
Q4 2023 -122,800 Reduce 20.76% 468,841 $82.38
Q3 2023 +591,641 New Buy 591,641 $78.36
Q1 2023 -1.75 M Sold Out 0 $0.00
Q4 2022 -1.13 M Reduce 39.13% 1.75 M $0.08
Q3 2022 +504,000 Add 21.24% 2.88 M $80.75
Q2 2022 +2.37 M New Buy 2.37 M $89.75
Q1 2022 -3.57 M Sold Out 0 $0.00
Q4 2021 +3.12 M Add 680.74% 3.57 M $103.45
Q3 2021 +257,500 Add 128.53% 457,841 $125.35
Q2 2021 +200,341 New Buy 200,341 $124.13
Q4 2020 -58,041 Sold Out 0 $0.00
Q3 2020 -2.09 M Reduce 97.29% 58,041 $103.93
Q2 2020 +1.96 M Add 1059.65% 2.14 M $91.70
Q1 2020 -27,904 Reduce 13.11% 184,896 $90.18
Q4 2019 -1.26 M Reduce 85.55% 212,800 $113.45
Q3 2019 -734,362 Reduce 33.28% 1.47 M $108.62
Q2 2019 +2.21 M New Buy 2.21 M $97.39
Q1 2019 -40,241 Sold Out 0 $0.00
Q4 2018 -1.7 M Reduce 97.69% 40,241 $90.95
Q3 2018 +1.74 M New Buy 1.74 M $98.37
Q1 2018 -1.43 M Sold Out 0 $0.00
Q4 2017 -4.97 M Reduce 77.61% 1.43 M $80.75
Q3 2017 +5.96 M Add 1374.08% 6.4 M $77.77
Q2 2017 +434,000 New Buy 434,000 $88.75
Q1 2017 -878,141 Sold Out 0 $0.00
Q4 2016 +686,900 Add 359.18% 878,141 $71.23
Q3 2016 -381,900 Reduce 66.63% 191,241 $86.40
Q2 2016 +573,141 New Buy 573,141 $86.77
Q4 2015 -531,441 Sold Out 0 $0.00
Q3 2015 +531,441 New Buy 531,441 $66.94

Renaissance Technologies (RenTech)'s Medtronic plc Investment FAQs

Renaissance Technologies (RenTech) first purchased Medtronic plc (MDT) in Q3 2015, acquiring 531,441 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Medtronic plc (MDT) for 38 quarters since Q3 2015.

Renaissance Technologies (RenTech)'s largest addition to Medtronic plc (MDT) was in Q3 2017, adding 6,397,513 shares worth $497.54 M.

According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 3,167,741 shares of Medtronic plc (MDT), valued at approximately $247.81 M.

As of the Q2 2026 filing, Medtronic plc (MDT) represents approximately 0.34% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Medtronic plc (MDT) was 6,397,513 shares, as reported at the end of Q3 2017.